Stereotaxis (STXS) Non-Current Receivables (2010 - 2020)
Stereotaxis (STXS) reported Non-Current Receivables of $95483.0 for Q1 2020, up 367.34% on a QoQ basis from $20431.0 in Q4 2013.
Stereotaxis (STXS) has 5 years of Non-Current Receivables data on file, last reported at $95483.0 in Q1 2020.
- Quarterly Non-Current Receivables changed N/A year-over-year to $95483.0 in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $95483.0 (changed N/A YoY) and the FY2013 annual result came in at $20431.0, down 72.09% from the prior year.
- Non-Current Receivables climbed to $95483.0 in Q1 2020 per STXS's latest filing, from $20431.0 in the prior quarter.
- Across five years, Non-Current Receivables topped out at $95483.0 in Q1 2020 and bottomed at $95483.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | - |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | - |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | - |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | - |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | - |
| 10 | Stereotaxis | 187.40 Mn | 172.78 Mn | 3.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 95,483.00 |
| Dec 31, 2013 | 20,431.00 |
| Sep 30, 2013 | 19,975.00 |
| Jun 30, 2013 | 19,521.00 |
| Mar 31, 2013 | 18,906.00 |
| Dec 31, 2012 | 73,199.00 |
| Sep 30, 2012 | 32,734.00 |
| Jun 30, 2012 | 31,581.00 |
| Mar 31, 2012 | 31,118.00 |
| Dec 31, 2011 | 51,892.00 |
| Sep 30, 2011 | 81,514.00 |
| Jun 30, 2011 | 79,730.00 |
| Dec 31, 2010 | 109,266.00 |